A University of Bristol spin-off has been awarded almost £1 million to bring a new technology to the market that could help to fight infections in the mouth and body. An enhanced form of chlorhexidine, the substance, named Pertinax, is said to offer improved properties compared with those of the original substance.
“We’re very excited about Pertinax’s potential,”
A proven antimicrobial agent, chlorhexidine has been used in a wide range of products and treatment processes to prevent and treat bacterial infections. Since it is a new formulation of the substance, Pertinax is reported to possess the same antibacterial properties, but without some of the shortcomings of the original formulation, such as short efficacy time. Possible future applications are its use in cements to reduce the failure rates of dental fillings.